Zepp Health Cash Flow from Investing Activities 2017-2025 | ZEPP
Zepp Health cash flow from investing activities from 2017 to 2025. Cash flow from investing activities can be defined as the total change in cash resulting from a companies investments
| Zepp Health Annual Cash Flow Investing (Millions of US $) |
|
|---|---|
| 2024 | $-2 |
| 2023 | $8 |
| 2022 | $-6 |
| 2021 | $-168 |
| 2020 | $-32 |
| 2019 | $-16 |
| 2018 | $-47 |
| 2017 | $-6 |
| 2016 | $-15 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.175B | $0.183B |
| Zepp Health Corp. developed a platform of proprietary technology including AI chips, biometric sensors and health data algorithms, which drive a broadening line of smart health products for consumers and analytics services for insurers, healthcare providers, employers, drug and treatment companies. Zepp Health Corp., formerly known as Huami Corporation, is based in CUPERTINO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.883B | 59.65 |
| Hims & Hers Health (HIMS) | United States | $14.668B | 152.40 |
| Doximity (DOCS) | United States | $11.054B | 51.17 |
| Tempus AI (TEM) | United States | $10.008B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.472B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.870B | 60.47 |
| Hinge Health (HNGE) | United States | $3.513B | 0.00 |
| Privia Health (PRVA) | United States | $2.388B | 163.25 |
| 10x Genomics (TXG) | United States | $1.713B | 0.00 |
| Phreesia (PHR) | United States | $1.608B | 0.00 |
| Enovis (ENOV) | United States | $1.544B | 8.61 |
| Azenta (AZTA) | United States | $1.530B | 71.11 |
| Schrodinger (SDGR) | United States | $1.520B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.476B | 0.00 |
| Omnicell (OMCL) | United States | $1.391B | 24.55 |
| Evolent Health (EVH) | United States | $1.162B | 99.00 |
| Claritev (CTEV) | United States | $0.636B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.532B | 0.00 |
| Standard BioTools (LAB) | United States | $0.524B | 0.00 |
| Veradigm (MDRX) | United States | $0.507B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.448B | 0.00 |
| Talkspace (TALK) | United States | $0.418B | 125.00 |
| TruBridge (TBRG) | United States | $0.315B | 698.67 |
| Outset Medical (OM) | United States | $0.300B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.256B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.243B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.212B | 0.00 |
| CapsoVision (CV) | United States | $0.190B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.161B | 0.00 |
| Pulmonx (LUNG) | United States | $0.127B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.122B | 0.00 |
| American Well (AMWL) | United States | $0.117B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.115B | 0.00 |
| CareCloud (CCLD) | United States | $0.100B | 3.81 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.080B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.077B | 0.00 |
| 111 (YI) | China | $0.060B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.052B | 0.00 |
| HeartBeam (BEAT) | United States | $0.039B | 0.00 |
| Zhongchao (ZCMD) | China | $0.026B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.012B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| PROFUSA (PFSA) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |